Ceftazidime-avibactam-based combination therapy for hospital-acquired central nervous system infections caused by carbapenem-resistant Klebsiella pneumoniae.
Int J Antimicrob Agents
; 61(5): 106777, 2023 May.
Article
in En
| MEDLINE
| ID: mdl-36905946
Key words
Full text:
1
Collection:
01-internacional
Health context:
3_ND
Database:
MEDLINE
Main subject:
Klebsiella Infections
/
Central Nervous System Infections
/
Carbapenem-Resistant Enterobacteriaceae
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Int J Antimicrob Agents
Year:
2023
Document type:
Article